ALTARGO
ALTARGO
Discontinued
DIN Number
02307502
Drug Class
Human
Market Date
N/A
Company
HC
GlaxoSmithKline Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02307502
AIG Number0152454001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
D06AX13 RETAPAMULIN
Product Specifications
Dosage FormOintment
Route of AdministrationTopical
AHFS Classification84:04.04
Health Canada Classification
ACTIVE INGREDIENTS (1)
RETAPAMULINActive
Strength: 1 %
Monograph: RETAPAMULIN